Welcome to the Marble Center for Cancer Nanomedicine

Announcing the 2020-2021 Class of Convergence Scholars!

Learn more about the new class of Convergence Scholars here.

Spotlight on the U.S. Patent and Trademark Office website: a journey of innovation with Marble Center Director, Dr. Sangeeta Bhatia.

Since she was a child, Sangeeta Bhatia has enjoyed figuring out how things work. Now a biomedical researcher, MIT professor, and biotech entrepreneur, she has invented human microlivers to study drug metabolism and liver disease as well as nanoparticles that help diagnose, study, and treat ailments like cancer. You can access the spotlight feature on the USPTO website.

REGISTER HERE: Marble Center Distinguished Seminar with Dr. Mark Bathe, Monday July 20, 2-3pm. (Zoom access shared following registration!)

Dr. Mark Bathe is a Full Professor in the Department of Biological Engineering at MIT, an Associate Member of the Broad Institute of MIT & Harvard, Co-Chair of the MIT New Engineering Education Transformation, and Chair of the MIT Committee on Student Life.

Belcher lab and collaborators win STAT Madness with technology to see tiny ovarian tumors

In this year’s STAT Madness, a bracket-style competition to honor the best in recent biomedical research, the Belcher Lab exploited carbon nanotubes to tackle cancer. Read more about their approach here.

T cell backpacks

Enhancing cancer immunotherapy with nanomedicine

Click here to access Irvine's Lab latest review in Nature Reviews Immunology on how nanomedicine-based treatment strategies are well suited to immunotherapy.

Making deeper Inroads against ovarian cancer

At the Marble Center for Cancer Nanomedicine, the Hammond, Belcher, and Bhatia research groups are working on particles that take more complex approaches to targeting tumors and delivering a wide variety of substances, including new kinds of diagnostic agents as well as cancer-killing therapies. Click here to learn more. Photo credit: Paulo Campos; original article from Proto Magazine.

Robert Langer Wins 2019 Dreyfus Prize

The Camille and Henry Dreyfus Foundation has announced that Robert Langer, Institute Professor at Massachusetts Institute of Technology and Marble Center faculty, has won the 2019 Dreyfus Prize in the Chemical Sciences. The award ceremony will be held at MIT on September 26 and will include a lecture by Dr. Langer. Click here to learn more.


Dr. Angela Belcher Commands a Virus to Hunt a Deadly Cancer

Dr. Angela Belcher engineers nanoparticles to light up tiny tumors that doctors can’t see. Click here to learn more. Illustration by Agata Nowicka; original article by T. Ready, Neo.Life.

Celebrating National Nanotechnology Day

Celebrating National Nanotechnology Day

Dr. Sangeeta Bhatia's commentary for National Nanotechnology Day featured by the National Academy of Sciences. Click here to read the commentary.

Converging on cancer at the nanoscale

Converging on cancer at the nanoscale

Marking its first anniversary, the Koch Institute’s Marble Center for Cancer Nanomedicine goes full steam ahead. See the article in MIT News here.

Nanoscale dream team: 3 MIT professors use tiniest of tools against cancer

Drs. Belcher, Bhatia, and Hammond are innovating at the tiniest scale—developing tools to see, target and kill cancer cells before they can cause any harm. See article here.

Robert Langer, The Delivery Man

Robert Langer, The Delivery Man

The downfall of many drugs is that they are not taken regularly or as prescribed. Robert Langer has developed a polymer that could solve this problem. See article herePhoto credit: Nick D Burton; original article by Kathryn Nave from WIRED Magazine.

Image gallery for National Nanotechnology Day

Image gallery for National Nanotechnology Day

In honor of the first annual National Nanotechnology Day, the Koch Institute for Integrative Cancer Research at MIT presents an interactive peek into how researchers across the MIT campus are using nanomaterials to explore and improve the world. Source: The Koch Institute for Integrative Cancer Research at MIT.